SCHEMBL380421

SCHEMBL380421

NC(=O)C(Br)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2686724 0.79
SCHEMBL1669878 0.78
SCHEMBL16401948 0.75 CYP2C19 (0.44)
SCHEMBL5040518 0.72
SCHEMBL1771381 0.72
SCHEMBL3911470 0.72
SCHEMBL6533057 0.72
SCHEMBL310693 0.72
Ammonia Solution, Strong SCHEMBL9801972 0.72
SCHEMBL10639212 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2106387-B1 METHOD TO CONTROL REVERSE OSMOSIS MEMBRANE BIOFOULING IN DRINKING WATER PRODUCTION DOW GLOBAL TECHNOLOGIES LLC (US) 2012-01-25 EP claimed
US-20100096326-A1 METHOD TO CONTROL REVERSE OSMOSIS MEMBRANE BIOFOULING IN MUNICIPAL WATER PRODUCTION DOW GLOBAL TECHNOLOGIES LLC 2010-04-22 US claimed
EP-2106387-A1 METHOD TO CONTROL REVERSE OSMOSIS MEMBRANE BIOFOULING IN DRINKING WATER PRODUCTION Dow Global Technologies Inc. (US) 2009-10-07 EP claimed
WO-2008091453-A1 METHOD TO CONTROL REVERSE OSMOSIS MEMBRANE BIOFOULING IN DRINKING WATER PRODUCTION DOW GLOBAL TECHNOLOGIES INC. (US) 2008-07-31 WO claimed
EP-0285209-B1 SUSTAINED RELEASE MICROBIOLOGICAL CONTROL COMPOSITION AND METHOD FOR BIOLOGICAL CONTROL USING SAID COMPOSITION THE DOW CHEMICAL COMPANY (US) 1993-05-05 EP claimed
US-4800082-A HALOGENATED AMIDE AND HYDROPHILIC POLYMER THE DOW CHEMICAL COMPANY (US) 1989-01-24 US claimed
EP-0285209-A2 Sustained release microbiological control composition and method for biological control using said composition THE DOW CHEMICAL COMPANY (US) 1988-10-05 EP claimed
US-4110424-A PROCESS FOR THE PRODUCTION OF CYANIC ACID AND CARBOXAMIDES POLAROID CORPORATION (US) 1978-08-29 US claimed
JP-57048971-A None JP disclosed
US-20230000773-A1 NOVEL HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS ARES CAPITAL CORPORATION, AS AGENT 2023-01-05 US disclosed
CN-115504934-A Naphthalimide-nitrone compound and preparation method and application thereof 中国医学科学院药物研究所 2022-12-23 CN disclosed
EP-4031527-A1 HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS ModernaTX, Inc. (US) 2022-07-27 EP disclosed
CN-114746398-A Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents 摩登纳特斯有限公司 2022-07-12 CN disclosed
WO-2021055849-A1 HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS MODERNATX, INC. (US) 2021-03-25 WO disclosed
US-4182805-A Decyanation POLAROID CORPORATION (US) 1980-01-08 US disclosed
US-4163798-A ALDEHYDE STABILIZER THE DOW CHEMICAL COMPANY (US) 1979-08-07 US disclosed
US-4163795-A Stabilized aqueous amide antimicrobial composition THE DOW CHEMICAL COMPANY (US) 1979-08-07 US disclosed
US-4163797-A CARBAMOYL OR SULFAMOYL STABILIZER THE DOW CHEMICAL COMPANY (US) 1979-08-07 US disclosed
US-4163796-A QUATERNARY AMMONIUM OR PHOSPHONIUM SALT THE DOW CHEMICAL COMPANY (US) 1979-08-07 US disclosed
US-4110424-A PROCESS FOR THE PRODUCTION OF CYANIC ACID AND CARBOXAMIDES POLAROID CORPORATION (US) 1978-08-29 US disclosed